Suscribirse

Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart Failure - 02/01/20

Doi : 10.1016/j.amjmed.2019.05.047 
Wendy McCallum, MD, MS a, Hocine Tighiouart, MS b, c, Michael S. Kiernan, MD, MS d, Gordon S. Huggins, MD d, Mark J. Sarnak, MD, MS a,
a Division of Nephrology, Tufts Medical Center, Boston, Mass 
b Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Mass 
c Tufts Clinical and Translational Science Institute, Tufts University, Boston, Mass 
d Division of Cardiology, Tufts Medical Center, Boston, Mass 

Requests for reprints should be addressed to Mark J. Sarnak, MD, MS, Box 391, Division of Nephrology, Tufts Medical Center, 800 Washington St, Boston, MA 02111.Division of NephrologyTufts Medical CenterBox 391800 Washington StBostonMA 02111

Abstract

Background

Acute declines in kidney function occur in approximately 20%-30% of patients with acute decompensated heart failure, but its significance is unclear, and the importance of its context is not known. This study aimed to determine the prognostic value of a decline in kidney function in the context of decongestion among patients admitted with acute decompensated heart failure.

Methods

Using data from patients enrolled in the Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome Study (CARRESS) and Diuretic Optimization Strategies Evaluation (DOSE) trials, we used multivariable Cox regression models to evaluate the association between decline in estimated glomerular filtration rate (eGFR) and change in N-terminal pro-b-type natriuretic peptide (NT-proBNP) with a composite outcome of death and rehospitalization, as well as testing for an interaction between the two.

Results

Among 435 patients, in-hospital decline in eGFR was not significantly associated with death and rehospitalization (hazard ratio [HR] = 0.89 per 30% decline, 95% confidence interval [CI] 0.74, 1.07), whereas decline in NT-proBNP was associated with lower risk (HR = 0.69 per halving, 95% CI 0.58, 0.83). There was a significant interaction (P = 0.002 unadjusted; P = 0.03 adjusted) between decline in eGFR and change in NT-proBNP where a decline in eGFR was associated with better outcomes when NT-proBNP declined (HR = 0.78 per 30% decline in eGFR, 95% CI 0.61, 0.99), but not when NT-proBNP increased (HR = 0.99, 95% CI 0.76, 1.30).

Conclusions

Decline in kidney function during therapy for acute decompensated heart failure is associated with improved outcomes as long as NT-proBNP levels are decreasing as well, suggesting that incorporation of congestion biomarkers may aid clinical interpretation of eGFR declines.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiorenal syndrome, Acute decompensated heart failure, Decongestion, Decline in kidney function


Esquema


 Funding: NIH Training Grant T32 DK007777.
 Conflicts of Interest: WMC, HT, MSK, and GSH declare none. MJS serves on the Steering Committee of a trial funded by Akebia.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2019  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 133 - N° 1

P. 115 - janvier 2020 Regresar al número
Artículo precedente Artículo precedente
  • Kissing Bugs Harboring Trypanosoma cruzi, Frequently Bite Residents of the US Southwest But Do Not Cause Chagas Disease
  • Nicole Behrens-Bradley, Shannon Smith, Norman L. Beatty, Maria Love, Nafees Ahmad, Patricia L. Dorn, Justin O. Schmidt, Stephen A. Klotz
| Artículo siguiente Artículo siguiente
  • Limitations of Electrocardiography for Detecting Left Ventricular Hypertrophy or Concentric Remodeling in Athletes
  • Kristofer Hedman, Kegan J Moneghetti, David Hsu, Jeffrey W Christle, Alessandro Patti, Euan Ashley, David Hadley, Francois Haddad, Victor Froelicher

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.